Results 71 to 80 of about 7,741 (242)
Pediatric Dermatology, EarlyView.ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung +5 more
wiley +1 more source
Pediatric Dermatology, EarlyView.ABSTRACT A 16‐year‐old girl presenting with calcinosis cutis and localized scleroderma subsequently developed delayed‐onset idiopathic inflammatory myopathy five years after initial skin involvement. Despite the absence of typical dermatomyositis features and negative myositis‐specific antibodies, whole‐body MRI revealed extensive subclinical muscle ...
Edoardo Marrani +5 more
wiley +1 more source
Frontiers in Medicine, 2021 While mucocutaneous manifestations of COVID-19 have been frequently reported and added to our knowledge every day during the pandemic, another issue is the COVID-related diseases that can present as intensified lesions of underlying diseases, a new ...
Z. Lotfi +4 more
semanticscholar +1 more source
ACR Open Rheumatology, Volume 8, Issue 6, June 2026.Objective The aim of this study was to develop and validate International Classification of Diseases (ICD) code–based algorithms for identifying systemic sclerosis (SSc) cases within electronic health record (EHR) data and to evaluate algorithm performance. Methods We identified patients with at least one ICD, Ninth Revision (ICD‐9)/ICD‐10 code for SSc
Gulsen Ozen +3 more
wiley +1 more source
Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea
Dermatology Practical & ConceptualIntroduction: Morphea, also known as localized scleroderma, is a rare fibrosing inflammatory disease of unknown pathogenesis. Objectives: Although the genetic basis for morphea is important, the evaluation of Toll-like receptors (TLR) in this disease ...
Hilal Ayvaz Celik +4 more
doaj +1 more source
Case of generalized morphea complicated with systemic sclerosis
Dermatology Reports, 2021 Dear Editor, Localized scleroderma (LSc; morphea) is a rare fibrosing disease of the skin and underlying tissues, which is different from systemic sclerosis (SSc).
Soichiro Sawamura +4 more
doaj +1 more source
Apremilast as a treatment for morphea: A case series
JAAD Case Reports, 2021 IL: interleukin PDE4: phosphodiesterase 4 INTRODUCTION Morphea, or localized scleroderma, is a skin condition characterized by erythematous and indurated inflammatory lesions that progress to atrophic and sclerotic plaques.
Merav Koschitzky, S. Khattri
semanticscholar +1 more source
Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective
JEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek +3 more
wiley +1 more source
Extensive morphea profunda with autoantibodies and benign tumors: A rare case report
Indian Dermatology Online Journal, 2012 The term deep morphea describes a variant of morphea (localised scleroderma) in which inflammation and sclerosis are found in the deep dermis, panniculus, fascia or superficial muscle. It is sometimes associated with autoantibodies. We report the case of
Leelavathy Budamakuntla +1 more
doaj +1 more source
Morphea induced by SARS‐CoV‐2 infection: A case report
International Journal of Dermatology, 2021 Morphea induced by SARS-CoV-2 infection: A case report Dear Editor, The widespread diffusion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the coronavirus family responsible for Coronavirus disease (COVID-19), is still in ...
F. Pigliacelli +5 more
semanticscholar +1 more source